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Abstract
 
The major histocompatibility complex (MHC)-dependent presentation of processed tissue-
specific self-antigens can contribute to either peripheral (extrathymic) tolerance or the differen-
tiation of autoreactive T cells. Here, we have studied the MHC class II molecule presentation
of gastric parietal cell (PC)-specific H
 
 
 
/K
 
 
 
-ATPase, which induces a destructive autoimmune
gastritis in BALB/c mice lacking CD4
 
  
 
CD25
 
  
 
regulatory T cells. Immunofluorescence mi-
croscopy showed physical association of CD11c
 
  
 
dendritic cells (DCs) with PCs in the gastric
mucosa. H
 
 
 
/K
 
 
 
-ATPase protein was found within vesicular compartments of a few CD11c
 
 
 
DCs only in the draining gastric lymph node (LN) and these antigen-containing DCs increased
markedly in number with the onset of tissue destruction in autoimmune animals. Both CD8
 
 
 
hi
 
and CD8
 
 
 
lo 
 
gastric DCs, but not peripheral or mesenteric DCs, showed evidence of constitu-
tive in vivo processing and presentation of H
 
 
 
/K
 
 
 
-ATPase. These data provide direct support
for a widely held model of local tissue antigen uptake and trafficking by DCs in normal ani-
mals and demonstrate that DCs in the draining LN can present a tissue-specific self-antigen
under noninflammatory conditions without fully deleting autoreactive T cells or inducing
active autoimmunity.
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Introduction
 
The immune system recognizes and efficiently eliminates
invading pathogens without typically causing extensive
damage due to effector responses to self-antigens. Such
functional discrimination between foreign and self depends
in part on processed antigen displayed by thymic presenting
cells (APC) whose recognition purges the repertoire of
strongly reactive T cells (1, 2). Even so, peripheral mecha-
nisms of tolerance induction are required to eliminate or
limit the activation of T cells with specificities for those pe-
ripheral self-antigens not available to developing thy-
mocytes (3, 4).
Recent experiments indicate that (CD11c
 
 
 
) dendritic
 
cells (DCs)
 
* 
 
that have not been activated by pathogen-
related or endogenous inflammatory stimuli can make a
major contribution to peripheral tolerance by inducing the
deletion of specific T cells (5). Based on these findings, it
has been proposed that under nonpathologic conditions,
DCs continuously sample self-antigens from normal pe-
ripheral tissues and delete the relevant T cells by presenting
processed forms of these antigens after migration to the
draining LN (6, 7). However, only a few studies have pro-
vided direct evidence for such a sequence of events involv-
ing normal tissue antigens (for review see reference 7). In
addition, reports that nonactivated DCs tend to store pro-
teins that enter the endocytic pathway rather than process
them for MHC class II molecule presentation raise some
questions about this model in its simplest form (8–10).
A better understanding of the role of DC antigen presen-
tation in self-tolerance and autoimmunity thus requires a
clearer definition of the cells that acquire tissue antigens
under normal or pathologic conditions and the extent to
which they actively process and present these antigens. We
have chosen the gastric proton pump H
 
 
 
/K
 
 
 
-ATPase as a
 
model system for the study of these questions. H
 
 
 
/K
 
 
 
-
ATPase expression is restricted to gastric parietal cells (PCs)
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Constitutive Tissue Antigen Presentation by Dendritic Cells
 
and this protein is a primary target autoantigen for the ex-
perimental autoimmune gastritis (AIG) that develops after
the thymectomy of BALB/c mice at day 3 of life or after
the transfer of CD4
 
  
 
CD25
 
  
 
T cells to lymphopenic
BALB/c
 
nu/nu 
 
mice (for review see references 11 and 12).
Here, we report direct visualization of CD11c
 
  
 
CD8
 
 
 
 
 
DCs as the cells responsible for the uptake of this self-anti-
gen in the stomach, as well as the selective transport to and
constitutive presentation of processed H
 
 
 
/K
 
 
 
-ATPase by
DCs within the draining gastric LN of healthy animals. Be-
cause such antigen-presenting DCs are found in animals
still possessing functional autoaggressive T cells, these re-
sults suggest that “quiescent” DCs do not always fully de-
plete the repertoire of T cells reactive with some tissue-spe-
cific antigens. This study also provides evidence that tissue
destruction by immune cells markedly augments the num-
ber of antigen-containing DCs in the draining LN as well
as the antigen presentation function of these DCs, provid-
ing a possible explanation for disease amplification and
epitope spreading (13) during autoimmune processes.
 
Materials and Methods
 
Antigen-specific T Cells and Animals.
 
An OVA 323–339-spe-
cific, I-A
 
d
 
–restricted T cell line was established from DO11.10
transgenic mice by repetitive cycles of antigen stimulation and
rest in vitro. The generation of the CD4
 
  
 
H
 
 
 
/K
 
 
 
-ATPase 
 
 
 
chain peptide 630–641-reactive, I-A
 
d
 
–restricted T cell clone
TXA-23 has been previously described (14).
4–6-wk-old BALB/c mice were obtained from the National
Cancer Institute. DO11.10 transgenic mice expressing a TCR
specific for OVA peptide 323–339 presented by I-A
 
d 
 
(15) were
obtained from Taconic. 4–6-wk-old BALB/c
 
nu/nu 
 
mice were
purchased from Charles River Laboratories, housed in sterile
cages, and given autoclaved food and acidified water. TCR trans-
genic mice expressing the receptor of the TXA-23 clone were
generated as previously described (16) and backcrossed eight gen-
erations onto the BALB/c background. All animals were main-
tained in our animal facility and cared for in accordance with in-
stitutional guidelines for animal welfare.
 
Medium, Reagents, and Antibodies.
 
Cell cultures were per-
formed in RPMI 1640 supplemented with 10% heat-inactivated
FCS, 100 U/ml penicillin, 100 
 
 
 
g/ml streptomycin, 2 mM 
 
l
 
-glu-
tamine, 10 mM Hepes, 0.1 mM nonessential amino acids, and
1 mM sodium pyruvate (cRPMI 1640; all from Biofluids). mAbs
and/or fluorochrome conjugates against CD2 (RM2-5), CD3
(2C11), CD4 (RM4-4), CD8
 
  
 
(Ly-2), CD11b (M1/70), CD11c
(HL3), CD19 (1D3), CD40 (3/23), CD45R/B220 (RA3-6B2),
CD80 (16-10A1), CD86 (GL-1), MHC class II I-A
 
d
 
/I-E
 
d
 
 (2G9),
and IFN-
 
  
 
(XMG1.2) were obtained from BD Biosciences. mAb
against CD28 was obtained from Harlan and cells producing
mAbs against CD11c (N418; reference 17) were obtained from
American Type Culture Collection (ATCC). Ab to DEC-205
(NLDC 145) was from Bachem. Mouse mAb 2G11 against the 
 
 
 
subunit of the H
 
 
 
/K
 
 
 
-ATPase was provided by J.G. Forte, Uni-
versity of California, Berkeley, CA.
The H
 
 
 
/K
 
 
 
-ATPase 
 
  
 
chain peptide (PITAKAIAASVG,
amino acid [aa] 630–641) and OVA peptide (ISQAVHAA-
HAEINEAGR, aa 323–339) were obtained through the NIAID
Peptide Synthesis Unit and determined to be free of LPS contam-
ination using a chromogenic Limulus amebocyte lysate test kit
from BioWhittaker. Native H
 
 
 
/K
 
 
 
-ATPase protein was pre-
pared from rabbit stomach as previously described (18).
Chloroquine (Sigma-Aldrich) was prepared as a 100-
 
 
 
M stock
solution in RPMI 1640.
 
Induction and Evaluation of AIG.
 
AIG was induced in BALB/
c
 
nu/nu 
 
mice as previously described (19) with CD4
 
  
 
T cells iso-
lated using mouse CD4 subset columns (R&D Systems) from
which CD25
 
  
 
CD4
 
  
 
T cells were depleted using the VARIO-
MACS technique (Miltenyi Biotec). Recovered CD4
 
  
 
CD25
 
  
 
T
cells were resuspended in PBS and injected intravenously into
BALB/c
 
nu/nu 
 
mice (3 
 
  
 
5 
 
  
 
10
 
6 
 
cells/animal). After 4 wk, the an-
imals were killed and gastric LNs, peripheral LNs, and stomachs
were collected. For histological evaluation of gastritis, stomachs were
fixed in 4% paraformaldehyde and sectioned. The sections were
stained with hematoxylin and eosin (American Histolabs).
 
Fluorescence Immunohistochemistry.
 
LNs, spleens, and stomach
fragments were frozen in embedding medium (Cryoform; Inter-
national Equipment Co.). 7-
 
 
 
m frozen sections were cut, air-
dried, and fixed in acetone for 10 min at 
 
 
 
20
 
 
 
C, and then rehy-
drated in Tris-buffered saline containing 0.05% Tween 20. After
blocking for 30 min with PBS/10% FCS/5% milk powder, the
sections were incubated with N-418 (anti-CD11c) hybridoma
supernatant (ATCC) followed by incubation with Texas red
(TXRD)-conjugated goat anti–Armenian hamster IgG (Jackson
ImmunoResearch Laboratories). For double labeling, the sections
were first stained as described above and then additionally stained
with FITC-labeled Ab or with rat anti–mouse Ab followed by
FITC-conjugated mouse anti–rat IgG (Jackson ImmunoResearch
Laboratories). After staining, the sections were washed, mounted
with ProLong Antifade Kit (Molecular Probes), and allowed to
dry overnight. Irrelevant isotype-matched Ab (BD Biosciences)
were used as controls to validate the specificity of staining.
 
Enzymatic Immunohistochemistry.
 
After blocking endogenous
peroxidase in 0.3% H
 
2
 
O
 
2
 
, the sections were incubated with
2G11-FITC or an isotype-matched control, followed by mouse
anti–FITC horseradish peroxidase (HRPO)-labeled Ab (Chimi-
con International Inc.). HRPO localization was revealed using a
metal-enhanced diaminobenzidine substrate (Pierce Chemical
Co.). Pictures were taken with the bright field setting of the mi-
croscope and additionally analyzed using the public domain NIH
image program (developed at the United States NIH and avail-
able at http://rsb.info.nih.gov/nih-image/). Images were
scanned and analyzed as two-dimensional arrays of pixels (picture
elements). Pixels are represented by 8-bit unsigned integers,
ranging in value from 0–255. 0 pixels are displayed as white and
those with a value of 255 as black. Positive staining events were
displayed in a surface plot view and in a threshold histogram plot
profile. In the threshold histogram plot profile only gray levels
are displayed beyond a defined background level that had been
set to 0.
 
Microscopy.
 
The stained sections were photographed on a
Leica compound microscope (Leica Camera AG) with a 10
 
  
 
air
objective or a 40
 
 
 
, 63
 
 
 
, or 100
 
  
 
oil immersion objective con-
nected to a digital video camera and analyzed using Openlab soft-
ware (Improvision Inc.), Adobe Photoshop 6.0 (Adobe Systems),
and the public domain NIH image program. For confocal mi-
croscopy, images were collected on a Leica TCS-NT/SP confo-
cal microscope with a 40
 
  
 
or 63
 
  
 
oil immersion objective
(Leica), zoom4. Fluorochromes were excited using an argon laser
at 488 nm for FITC and a krypton laser at 568 nm for TXRD.
Detector slits were configured to minimize any cross talk be-
tween the channels. Z-stacks (optical sections) of the images were
collected with an optical thickness of 0.2 mm. Images were pro- 
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cessed using the Leica TCS-NT/SP software (version 1.6.587),
Imaris 3.1.1 (Bitplane AG), Adobe Photoshop 6.0 (Adobe Sys-
tems), and Canvas 7 Standard Edition (Deneba Systems, Inc.).
 
Cell Preparation.
 
Gastric, peripheral (inguinal, brachial, and
axillary), and mesenteric LNs were removed and pooled sepa-
rately. Single cell suspensions were prepared by collagenase/
DNase digestion for 30 min at 37
 
 
 
C and washed with PBS/
2.5mM EDTA containing 0.2% BSA. CD11c
 
  
 
DCs were isolated
from these suspensions using the VARIOMACS technique and
microbeads coated with Ab against CD11c (Miltenyi Biotec).
The positively selected CD11c
 
  
 
DCs were collected and immedi-
ately used for additional phenotypic or functional analysis. Alter-
natively, for the isolation of distinct APC types, cells were first in-
cubated with directly labeled MACS
 
® 
 
microbeads against CD19
and both the positively selected CD19
 
  
 
B cells and the negatively
selected cell fraction were collected. On average, 98 
 
  
 
0.5% of
positively selected cells were B cells as determined by FACS
 
®
 
analysis. CD11c
 
  
 
DCs were subsequently isolated from the nega-
tively selected fraction as described above and again both the pos-
itively selected CD11c
 
  
 
DCs and the negatively selected cell frac-
tion were collected. On average, 91 
 
  
 
2% of positively isolated
cells were CD11c
 
 
 
. The remaining negatively selected fraction
consisted mainly of T cells as determined by the expression of
CD3
 
  
 
on 
 
 
 
95% of the cells. Distinct DC subsets were isolated by
incubating single cell suspensions with biotinylated mAb against
CD2, CD3, and CD19 followed by the incubation with strepta-
vidin MACS
 
® 
 
microbeads. The negatively selected cells were ad-
ditionally incubated with anti-CD8
 
  
 
MACS
 
® 
 
microbeads. The
positively selected CD8
 
 
 
hi 
 
cells were collected and found to con-
sist of 
 
 
 
85% CD8
 
 
 
hi 
 
CD11c
 
  
 
DCs. The negatively selected cells
were additionally incubated with anti-CD11c MACS
 
® 
 
micro-
beads and this time the positively selected CD8
 
 
 
lo 
 
CD11c
 
  
 
cells
were collected. Alternatively, the negatively selected cells were
stained with mAb against CD11c and CD8
 
 
 
. CD11c
 
  
 
CD8
 
 
 
hi
 
and CD11c
 
  
 
CD8
 
 
 
lo 
 
cells were sorted on a FACSVantage™
(Becton Dickinson).
To produce gastric PCs, the stomach was removed and after
separating the gastric LN, a single cell suspension was prepared by
passing the mucosa through a wire mesh into PBS containing 1
mM EDTA. Cells were washed twice and layered over a 30%
Percoll gradient, and then centrifuged for 20 min at 2,000 rpm.
Cells at the interface were harvested and washed twice in PBS
with 0.2% BSA and 1 mM EDTA. The majority of cells consisted
of PCs as confirmed by the intracellular staining of cytospin prep-
arations for H
 
 
 
/K
 
 
 
-ATPase using FITC-2G11.
 
TXA-23 Activation Assay.
 
APCs were either left without an-
tigen or incubated for the indicated time with H
 
 
 
/K
 
 
 
-ATPase
peptide, OVA peptide, or H
 
 
 
/K
 
 
 
-ATPase protein at the indi-
cated concentrations, or with a PC preparation at a ratio of 1:2
for the indicated time period. TXA-23 or DO.11.10 T cells were
then added to APCs at a ratio of 5:1 and the cells were cultured
for 16–18 h at 37
 
 
 
C in a humidified atmosphere in the presence
of 5% CO
 
2
 
. During the last 4 h of culture, 2 
 
 
 
M monensin was
added to the culture. Cells were harvested, washed, and immedi-
ately used for additional analysis.
To inhibit antigen processing during cell cultures, DCs were
treated with 75 
 
 M chloroquine for 30 min and then incubated
for 3 h without the addition of antigen or with 5  g/ml H /K -
ATPase peptide, 50  g/ml native rabbit H /K -ATPase protein,
or a PC preparation (DC/PC ratio   1:2) at 37 C. After the in-
cubation, TXA-23 T cells were added and the cells were co-
cultured for an additional 16–18 h in the continued presence of
chloroquine.
In Vivo Proliferation Assay. Thymocytes from 4-wk-old
TXA-23 TCR transgenic female mice were prepared as a single
cell suspension in HBSS buffer containing 5% FCS and 10 mM
Hepes. The cells were then washed three times in PBS, resus-
pended to 107 cells/ml, and incubated for 8 min at room temper-
ature in 1  M carboxyfluorescein succinimidyl ester (CFSE).
The incorporation of dye was stopped by incubation in an equal
volume of FCS followed by washing in HBSS buffer. 5   106 la-
beled cells were transferred intravenously into BALB/c wild-type
females. 3 d later, gastric and mesenteric LNs were removed and
single cell suspensions were prepared. Live cells gated on CD4
were analyzed by flow cytometry for the intensity of CFSE stain-
ing as an indication of the extent of cell division.
Flow Cytometry. Cell suspensions were incubated with anti-
Fc receptor Ab (2.4G2; BD Biosciences) and stained with the
indicated FITC-, PE-, CyChrome-, allophycocyanin-labeled or
biotinylated Ab for 15 min at 4 C in PBS containing 2.5 mM
EDTA and 0.2% BSA. For staining with biotin-conjugated pri-
mary Ab, the cells were washed twice with PBS/EDTA/BSA
and subsequently incubated with the second step reagent
streptavidin-allophycocyanin. For intracellular cytokine stain-
ing, monensin-treated cells were fixed in 4% paraformaldehyde
for 5 min at 37 C, washed, and stained in buffer containing
0.1% saponin. Cells were analyzed on a FACSCalibur® cytome-
ter (Becton Dickinson) using CellQuest™ (Becton Dickinson)
and FlowJo® (TreeStar) software. Irrelevant isotype-matched Ab
(BD Biosciences) were used as controls to validate the specificity
of staining.
Online Supplemental Material. Triple stainings of sections of a
gastric LN from a healthy BALB/c mouse are shown in Fig. S1.
Sections were stained for both H /K -ATPase (green) and
CD11c (red) as described above as well as for CD3, CD19, MHC
class II, DEC-205, CD11b, or CD8  (blue) using CyChrome
5–conjugated donkey anti–rat IgG (Jackson ImmunoResearch
Laboratories) as second step reagent. H /K -ATPase–containing
CD11c  DCs were found to reside in the T cell areas (Fig. S1 a,
left) but not B cell areas (Fig. S1 a, right) of the gastric LN. H /
K -ATPase  CD11c  DCs expressed MHC class II (Fig. S1 b,
first and second panels) molecules and the majority was DEC-
205   (Fig. S1 b, third and fourth panels). H /K -ATPase 
CD11c  DCs could either be CD8   (Fig. S1 c, first and second
panels) or CD8   (Fig. S1 c, third and fourth panels) as well as
CD11b  (Fig. S1 d, first and second panels) or CD11b  (Fig. S1 d,
third and fourth panels). The online supplemental figure is avail-
able at http://www.jem.org/cgi/content/full/20020991/DC1.
Results
H /K -ATPase Association with DCs in the Gastric
LNs. DCs have been suggested to continuously transport
tissue-specific self-antigens to the draining LNs and present
processed forms of these antigens to both CD4  (20, 21)
and CD8  (22, 23) T cells. Presently, reagents suitable for
direct visualization of specific peptide–MHC class I or II
combinations are only available for a limited set of deter-
minants (24–29). In the absence of such reagents for the
H /K -ATPase/I-Ad determinant, we first attempted to
identify cells that present the H /K -ATPase self-antigen
based on the presence of the source antigen itself. For this
purpose, we used a mouse mAb (2G11) against the H /
K -ATPase   subunit (30). Fig. 1 a shows hematoxylin1082 Constitutive Tissue Antigen Presentation by Dendritic Cells
and eosin staining of the gastric mucosa as well as immu-
nofluorescence staining with 2G11 mAb. 2G11 selectively
stained cells in the PC layer. No H /K -ATPase expres-
sion could be detected in sections of the duodenum or the
colon (not depicted).
Using the 2G11 mAb, we examined whether H /K -
ATPase could be detected in the draining gastric LN and
whether it was associated with DCs. Localized reactivity
was seen in gastric LN sections from untreated animals, but
not in sections from mesenteric or peripheral LN or spleen.
Although detectable, the frequency of H /K -ATPase sig-
nals was low in the gastric LN of normal healthy mice (on
average 5 to 6 positive staining events were detected in 60
tissue sections). This H /K -ATPase reactivity was exclu-
sively associated with CD11c  DCs (Fig. 1 b) that resided
in the T cell areas of the gastric LN (Fig. S1). Their low
frequency precluded multiplex staining analysis by flow cy-
tometry (unpublished data). Microscopic analysis, however,
did show that these rare antigen-containing cells also ex-
pressed MHC class II molecules and that most were DEC-
205 . CD8   and CD8   as well as CD11b  and CD11b 
DCs contained the H /K -ATPase antigen (Fig. S1). To
gain more information about the physical relationship be-
tween the H /K -ATPase self-antigen and DCs, laser
scanning confocal microscopy was performed (Fig. 1 c).
This analysis showed an intracellular staining pattern for the
H /K -ATPase (Fig. 1 c, first and second panels). A 3D
reconstruction of the whole cell was created from the im-
age information. By decreasing the opacity of the CD11c
surface staining (red), the intracellular cytoplasmic localiza-
tion of the H /K -ATPase staining (green) could be
clearly visualized (Fig. 1 c, third and fourth panels).
Physical Contact between DCs and H /K -ATPase–express-
ing PCs in the Stomach. Gastric LN DCs containing H /
K -ATPase could acquire this antigen locally in the stom-
ach tissue and subsequently migrate to the draining LN or
H /K -ATPase could reach afferent lymphatic vessels and
be taken up by DCs resident in the draining LN. To
address this question, stomach sections were costained
with anti–H /K -ATPase mAb and mAb against DCs
(CD11c). CD11c  DCs were found between the PC layer
and the muscularis mucosa in close association with
2G11  PCs. These MHC class II  cells could also be
stained with mAb to CD11b but not to CD8  (unpub-
lished data). Laser scanning confocal microscopy provided
evidence that DCs in the stomach can acquire H /K -
ATPase from PCs (Fig. 1 d). Thus, at least some DCs con-
stitutively residing in the stomach tissue appear to acquire
Figure 1. Immunofluorescence staining of H /K -
ATPase and DCs in gastric LN and stomach sections.
(a) Sections of gastric tissue from healthy, untreated
BALB/c mice were stained with hematoxylin and eosin
(left) or with FITC-2G11, specific for the   subunit of
gastric H /K -ATPase (right). (b) Sections of gastric
LN, peripheral LN, mesenteric LN, and spleen from
healthy BALB/c mice were stained with FITC-2G11
(green) with anti–CD11c-TXRD (red). Positive stain-
ing with the anti–H /K -ATPase mAb was detected
in sections of gastric LN (circles). (c) Sections of a gas-
tric LN from a healthy BALB/c mouse stained for both
H /K -ATPase (green) and CD11c (red) (first panel).
Laser scanning confocal microscopy was conducted on
a similarly stained gastric LN section. One individual
optical section in the z-plane is shown with cross-sec-
tional profiles in the y and x axes (second panel). A 3D
reconstruction of the whole cell was produced from
these image data (third panel) and the intracellular lo-
calization of the H /K -ATPase staining (green) was
visualized by decreasing the opacity of the CD11c
staining (red; fourth panel). (d) A stomach section from
a healthy BALB/c mouse stained for both H /K -
ATPase (green) and CD11c (red; first panel). Laser
scanning confocal microscopy was conducted on a sim-
ilarly stained stomach section. One individual optical
section in the z-plane is shown with cross-sectional
profiles in the y and x axes (second panel). A 3D recon-
struction of the whole cell was produced from these
image data, which demonstrates the juxtaposition of
H /K -ATPase  PCs (green) and a CD11c  DCs (red;
third panel). By decreasing the opacity of the CD11c
staining (red), the intracellular localization of H /K -
ATPase staining (green) was visualized (fourth panel).1083 Scheinecker et al.
the H /K -ATPase self-antigen in this organ and subse-
quently transport it to the draining LN where it can be vi-
sualized in intracellular vesicles.
Gastric but Not Peripheral DCs Induce the Activation of
TXA-23 T Cells. The preceding studies provide clear ev-
idence of tissue antigen acquisition by DCs and the selec-
tive accumulation of these antigen-containing cells in the
draining LN. Whether these DC actually process and
present such endocytosed antigen under noninflammatory
conditions is an unresolved question (8–10, 31). To address
this issue, we took advantage of a CD4  H /K -ATPase–
specific T cell clone, TXA-23, which produces Th1 cyto-
kines in response to I-Ad presentation of H /K -ATPase  
chain peptide aa 630–641 (14). Adopting the method orig-
inally used by Crowley et al. (32) to determine which cells
presented in vivo administered soluble antigen, the TXA-
23 T cell clone was used in in vitro antigen presentation
assays with cells isolated from the draining gastric and pe-
ripheral LN of healthy BALB/c mice. The activation of
TXA-23 cells was assessed by intracellular staining for IFN- .
As a control, DO11.10 T cells specific for OVA presented
by I-Ad were cultured and analyzed in parallel. In the ab-
sence of added antigen, gastric but not peripheral DCs in-
duced IFN-  production by the TXA-23 T cell clone (Fig.
2 a). In contrast, in the absence of added antigen, neither
gastric DCs nor peripheral DCs induced IFN-  production
by the DO11.10 T cell line. All DC populations induced
IFN-  production from both T cell lines upon the addition
of the appropriate peptide.
To estimate the level of H /K -ATPase presentation by
gastric DCs, we compared the stimulatory capacity of iso-
lated gastric DCs to that of peripheral DCs pulsed with
graded amounts of H /K -ATPase peptide. The activation
of TXA-23 T cells by unpulsed gastric DCs gave an IFN- 
response equal to that seen using peripheral DCs pulsed
with 0.2  M H /K -ATPase peptide, which is at least 10
times more than the minimal stimulatory concentration
(Fig. 2 b).
LNs draining the airways or the intestine are constantly
exposed to environmental antigens and irritants. This
might result in greater tonic activation of DCs in LNs
draining mucosal sites as compared with DCs (axillary
and brachial) draining subcutaneous tissues. To examine
whether their state of activation might account for the su-
perior stimulatory capacity of gastric DCs, we examined
the surface phenotype of gastric, peripheral, and mesenteric
DCs. DCs isolated from mesenteric LNs were included in
the analysis because they might resemble gastric LNs in
their exposure to chronic stimuli but differ from gastric
LNs in their repertoire of tissue-specific self-antigens. As
seen in Fig. 2 c, gastric and mesenteric DCs showed higher
MHC class II expression than peripheral DCs, whereas
similar expression was observed for B7.1/2 molecules and
CD40. Nevertheless, only gastric DCs, but not mesenteric
or peripheral DCs, were able to induce IFN-  production
by TXA-23 cells in the absence of added antigen.
Gastric DCs Constitutively Process and Present H /K -ATP-
ase Antigen In Vivo. Immature DCs are believed to have a
higher capacity for antigen uptake as compared with ma-
ture DCs (33–35) but do not form substantial numbers of
stable MHC class II–peptide complexes unless they are ex-
posed to inflammatory mediators (8–10, 36). Gastric
DCs phenotypically resemble immature/nonactivated DCs
(MHC class II , B71/2lo, and CD40lo) and immunofluo-
Figure 2. Gastric but not peripheral DCs induce the
activation of TXA-23 T cells. (a) Intracellular IFN- 
staining of TXA-23 and DO11.10 cells T cells. TXA-23
and DO11.10 T cells were cultured for 16–18 h alone
(no DC) in the presence of isolated gastric or periph-
eral DCs ( DC), and in the presence of DCs with
added H /K -ATPase peptide (final concentration
50 g/ml) or OVA peptide ( DC  peptide; final con-
centration 10 M). For TXA-23 cells, one representa-
tive experiment out of ten, and for DO11.10 one out
of four, is shown. Markers were set according to iso-
type-matched negative control staining in this and all
similar experiments. (b) The stimulatory capacity of
isolated gastric DCs compared with that of peripheral
DCs pulsed with graded amounts of H /K -ATPase
peptide. (c) Surface phenotype of gastric, peripheral,
and mesenteric DCs (filled) in comparison to isotype-
matched negative control staining (open). IFN-  re-
sponses of TXA-23 cells that were cultured for 16–18 h
in the presence of gastric, peripheral, or mesenteric
DCs in the absence of added antigen are also shown
(one representative experiment out of three).1084 Constitutive Tissue Antigen Presentation by Dendritic Cells
rescence analysis of tissue sections revealed the presence of
an intracellular pool of serologically recognizable H /K -
ATPase in some gastric DCs. Therefore, it was important
to determine whether the activation of TXA-23 cells by
gastric DCs reflected the constitutive in vivo presentation
of processed H /K -ATPase antigen or whether H /K -
ATPase protein in intracellular compartments is processed
and presented only upon DC activation and/or maturation
occurring in culture (37). Fixation of peptide-pulsed gastric
DCs with paraformaldehyde before the coculture com-
pletely inhibited any TXA-23 activation even using pep-
tide antigen (unpublished data). We therefore analyzed gas-
tric DCs for their capacity to activate TXA-23 T cells in
the presence of chloroquine. This drug inhibits acidifica-
tion and consequently much of the invariant chain and an-
tigen proteolysis that occurs within endocytic vesicles,
thereby interfering with the MHC class II–restricted pre-
sentation of antigens (38, 39).
TXA-23 cells were stimulated in the presence or absence
of chloroquine with either freshly isolated gastric DCs or
gastric DCs cultured with H /K -ATPase peptide or H /
K -ATPase protein. Gastric DCs were also exposed to PCs
in order to determine whether DCs would also be able to
form MHC–peptide complexes from phagocytosed cells, as
previously described (31). The concentrations of the H /
K -ATPase peptide and protein, as well as the gastric DC/
PC ratio, were adjusted to generate comparable numbers of
IFN-   TXA-23 cells in the absence of drug (Fig. 3 a,
top row). Chloroquine failed to inhibit the activation of
TXA-23 T cells by gastric DCs used in the absence of any
exogenous antigen or when pulsed with peptide antigen,
but it effectively inhibited the incremental activation of
TXA-23 T cells seen using protein- or PC-pulsed gastric
DCs (Fig. 3 a, bottom row).
Because it is difficult to exclude that post-isolation mat-
uration of isolated DCs might contribute to this evidence
for processed antigen display even in the presence of chlo-
roquine, we also used an in vivo approach to examine this
issue. Naive T cells from a transgenic animal expressing
the TXA-23 TCR (16) were labeled with CFSE and
transferred into normal BALB/c mice. 3 d later, the gastric
and peripheral LNs were removed and the adoptively
transferred T cells they contained were analyzed for evi-
dence of cell division based on dilution of the CFSE label.
Very few cells showed evidence of such proliferation in
the peripheral LN, but extensive division was seen among
these transgenic cells in the draining gastric LN (Fig. 3 b).
These results are consistent with the staining data showing
H /K -ATPase only in DCs of the gastric LN and the ev-
idence from in vitro experiments that this protein is ac-
tively processed by these gastric DCs in vivo. These find-
ings indicate that H /K -ATPase antigen is constitutively
processed and presented by gastric DCs in vivo in nonin-
flamed conditions.
CD8 hi and CD8 lo Gastric DCs Are Capable of TXA-23
T Cell Activation. Distinct populations of DCs can be dis-
tinguished according to the expression of surface mole-
cules, including CD8  (40–42). CD8   and CD8   DCs
have been suggested to play distinct roles in the induction
of tolerance versus immunity, respectively (43, 44). To de-
termine whether this might be due to the selective presen-
tation of self-antigens by one or the other DC subset, we
performed a sequential isolation of CD8 hi and CD8 lo
subsets from gastric DCs and analyzed both subsets sepa-
rately for their capacity to induce the activation of TXA-23
T cells. Even though only CD8   DCs were found to be
associated with PCs in the gastric mucosa, both CD8 hi
and CD8 lo DC populations from the gastric LN induced
similar activation of the TXA-23 clone in the absence of
added antigen (Fig. 4 a).
DCs Are the only APC in the Gastric LN Able to Activate
TXA-23 Cells. Previous studies have shown that aside
from DCs, B cells efficiently present circulating protein in
LN draining sites of inflammation (45) and even under non-
inflammatory conditions, B cells as well as DCs show MHC
class II–dependent antigen presentation of determinants de-
rived from soluble proteins present in extracellular fluid
(46). Therefore, distinct cell subsets were isolated from the
gastric LN and analyzed for their capacity to induce activa-
tion of the TXA-23 T cell clone. Only DCs induced IFN- 
production in the absence of added antigen, whereas B cells
were unable to do so (Fig. 4 b). Upon the addition of the
H /K -ATPase peptide, however, gastric B cells were
modestly effective in inducing IFN-  production.
Differential cosignaling, rather than differential TCR
ligand display, might account for the failure of gastric B
cells to activate the TXA-23 T cell clone in the absence of
Figure 3. Gastric DCs constitutively present H /K -ATPase antigen.
(a) TXA-23 cells were cultured for 16–18 h in the presence of gastric
DCs in the absence (DC alone) or presence of H /K -ATPase peptide
(DC peptide; 5  g/ml), H /K -ATPase protein (DC protein; 50  g/
ml), or a preparation of PCs (DC PCs; DC/PC ratio   1:2). Cultures
were performed either in the absence (top) or presence (bottom) of chlo-
roquine (final concentration 75  M). Primary data are shown as dot plots
of IFN-  intracellular staining. One representative experiment out of two
is shown. (b) Thymocytes expressing the TXA-23 TCR were labeled
with CFSE and transferred into BALB/c mice. After 3 d the transferred
transgenic T cells in the gastric and peripheral LN were analyzed for evi-
dence of cell division based on dilution of the CFSE label. One represen-
tative experiment out of four is shown.1085 Scheinecker et al.
added antigen (47). Therefore, additional experiments were
performed in the absence or presence of anti-CD28 mAb.
The relative stimulatory deficiency of the gastric B cells
compared with gastric DCs cultured in the presence of
H /K -ATPase peptide was partially overcome by directly
ligating the CD28 molecule on the TXA-23 T cells. How-
ever, no IFN-  production by the TXA-23 clone was seen
using B cells without adding specific antigen even with
anti-CD28 mAb present (Fig. 4 b), nor did these cells show
significant up-regulation of CD69, a sensitive indictor of
TCR engagement (unpublished data), suggesting that defi-
cient costimulation by gastric B cells does not obscure the
detection of processed tissue-specific antigen.
Increased Number of H /K -ATPase–containing DCs in
Animals with AIG. The induction of AIG is associated
with the progressive destruction and loss of PCs and chief
cells from the gastric mucosa in conjunction with varying
degrees of lymphoid infiltration (11). Concomitantly, H /
K -ATPase–reactive T cells accumulate in the draining
gastric LN but not peripheral LN (14, 18). In most autoim-
mune diseases, severity increases over time and is frequently
accompanied by epitope spreading. The latter has been as-
cribed to increased presentation of tissue antigen as effec-
tor-mediated damage makes more cellular material avail-
able for processing (for review see references 48 and 49).
One implication of these observations is that during T cell–
induced AIG there should be an increase in DCs con-
taining, and presumably presenting, a tissue antigen
such as H /K -ATPase. Therefore, we examined whether
changes in the distribution of H /K -ATPase Ag, H /
K -ATPase–containing DCs, or both, occurred after the
induction of AIG in BALB/cnu/nu mice.
Stomach sections of untreated BALB/cnu/nu mice closely
resembled stomach sections of normal BALB/c mice in
terms of morphology and H /K -ATPase staining (com-
pare Figs. 1 a and 5 a). 4 wk after adoptive transfer of
CD4  CD25  T cells, lymphoid aggregates at the base of
the mucosa and infiltrates of lymphocytes extending from
the submucosa into the mucosa were observed as consistent
with the induction of AIG (Fig. 5 a, third panel). The ex-
tent of H /K -ATPase staining in the stomach was con-
siderably reduced (Fig. 5 a, fourth panel), in accordance
with the previously described progressive depletion of PCs
in AIG (50). In comparison to untreated animals (Fig. 5 b,
first panel), there was a substantial increase in the frequency
of CD11c  DCs closely associated with remaining H /K -
ATPase–expressing PCs (Fig. 5 b, second panel). Addi-
tional analysis confirmed the very close juxtaposition of
CD11c  DCs with PC staining for H /K -ATPase (Fig. 5
b, third and fourth panels). The loss of H /K -ATPase
staining in the stomach tissue was paralleled by a striking
increase in 2G11 staining localized exclusively to CD11c 
DCs in the draining gastric LN of animals with AIG (Fig. 5
c, second panel), compared with the gastric LN of un-
treated animals (Fig. 5 c, first panel). Additional analysis by
laser scanning confocal microscopy showed an intracellular
staining pattern for the H /K -ATPase (Fig. 5 d, first
panel). A 3D reconstruction of the whole cell was created.
By decreasing the opacity of the CD11c staining (red), the
intracellular, cytoplasmic localization of the H /K -ATP-
ase staining (green) in multiple CD11c  DCs could be
clearly visualized (Fig. 5 d, second and third panels).
A quantitative immunohistochemical analysis of H /
K -ATPase in LN sections of untreated BALB/c mice and
animals with AIG was also performed. Positive staining for
H /K -ATPase was unambiguously identified in gastric,
but not peripheral, LN sections of untreated animals (Fig. 6
a). In animals with AIG, a substantial increase in the num-
ber of cells staining for H /K -ATPase was observed in
gastric, but not peripheral, LN sections (Fig. 6 b).
Increased H /K -ATPase–related T Cell Stimulatory Ca-
pacity of Gastric DCs During AIG. Absolute numbers of
CD11c  DCs in the gastric LN were found to be on aver-
age 11   7-fold increased in animals with AIG compared
with untreated BALB/cnu/nu mice. In contrast, the numbers
of CD11c  DCs in peripheral LNs were similar in un-
treated mice and animals with AIG (unpublished data). The
ability of gastric DCs from untreated BALB/cnu/nu mice to
evoke IFN-  from TXA-23 cells was compared with that
Figure 4. Phenotype and H /K -ATPase presenting function of differ-
ent cell populations. (a) Staining of isolated CD11c  DCs and of isolated
CD11c  CD8 hi and CD11c  CD8 lo subpopulations for MHC class II
molecule (I-Ad) and CD8  expression (top). TXA-23 cells were cultured
for 16–18 h in the presence of these CD11c  CD8 hi, CD11c  CD8 lo,
or unseparated CD11c  DCs in the absence of added antigen. The dot
plots show intracellular IFN-  production by TXA-23 cells (bottom).
One representative experiment out of three is shown. (b) TXA-23 cells
were cultured for 16–18 h in the presence of gastric LN DCs (gastric DC)
or gastric LN B cells (gastric B cells) either in the absence (APC alone) or
presence (APC peptide) of specific H /K -ATPase peptide (50  g/ml).
The dot plots show intracellular IFN-  production by TXA-23 cells.
Anti-CD28 mAb (final concentration 10  g/ml) was added to cocultures
of TXA-23 cells with either gastric LN DCs (gastric DC) or gastric LN B
cells (gastric B) in the absence or presence of H /K -ATPase peptide (50
 g/ml). One representative experiment out of three is shown.1086 Constitutive Tissue Antigen Presentation by Dendritic Cells
of gastric DCs from BALB/cnu/nu mice 4 wk after the in-
duction of AIG. Gastric LN DCs from normal BALB/
cnu/nu mice were less active in stimulating the TXA-23 clone
than those from normal BALB/c mice, in accordance with
previous reports (Fig. 7, week 0; references 51–53). Strik-
ingly, gastric DCs from BALB/cnu/nu with AIG showed a
Figure 5. Immunofluorescence staining of H  /K -
ATPase and DCs in the gastric LN and stomach sections of
animals with AIG. (a) Stomach sections from untreated
BALB/cnu/nu mice (stomach) and BALB/cnu/nu mice with
AIG (stomach AIG) were stained with hematoxylin and
eosin (first and third panel) or with FITC-2G11 (second
and fourth panel). (b) Double staining of stomach sections
of untreated BALB/cnu/nu mice (stomach) and BALB/cnu/nu
mice with AIG (stomach AIG) for H /K -ATPase (green)
and anti–CD11c-TXRD (red). Laser scanning confocal
microscopy was conducted on a similarly stained stomach
section from an animal with AIG. One individual optical
section in the z-plane is shown with cross-sectional profiles
in the y and x axes (third panel). A 3D reconstruction of
the whole cell was produced from these image data, which
demonstrates the juxtaposition of H /K -ATPase  PCs
(green) and a CD11c  DC (red; fourth panel). (c) Gastric
LN sections of an untreated BALB/cnu/nu mouse (gastric
LN) and a BALB/cnu/nu mouse with AIG (gastric LN AIG)
were stained with FITC-2G11 (green) and anti–CD11c-
TXRD (red). Positive staining with the anti–H /K -
ATPase mAb is restricted to CD11c  DCs (circles). (d) La-
ser scanning confocal microscopy was conducted on a sim-
ilarly stained gastric LN section from an animal with AIG.
One individual optical section in the z-plane is shown with
cross-sectional profiles in the y and x axes (left). A 3D re-
construction of the whole cell was produced from these
image data (middle) and the intracellular localization of the
H /K -ATPase staining (green) was visualized by decreas-
ing the opacity of the CD11c staining (red; right).
Figure 6. Quantitative immunohistochemical analy-
sis of H /K -ATPase in LN sections of untreated ani-
mals and animals with AIG. (a) Anti–H /K -ATPase
FITC-stained LN sections of untreated BALB/c mice
were incubated with secondary anti-FITC HRPO Ab
and developed using enhanced diaminobenzidine sub-
strate. Pictures were taken with the bright field setting
of the microscope (top) and additionally analyzed using
the public domain NIH Image program. Single peaks
represent positive staining for H /K -ATPase in the
threshold histogram plot profile (top) and in the surface
plot view (bottom) and can be detected in gastric LN,
but not peripheral LN, sections of untreated animals.
(b) In animals with AIG, an increase in the staining fre-
quency for H /K -ATPase was observed in gastric LN
(gastric LN AIG), but not in peripheral LN (peripheral
LN AIG), sections.1087 Scheinecker et al.
greater per cell capacity for stimulating IFN-  production
by TXA-23 than DCs from normal BALB/c (14% IFN- 
positive vs. the typical 4   2%; Fig. 7, wk 4). As with cells
from the gastric LN of normal mice, both CD8 hi and
CD8 lo DCs were active in TXA-23 stimulation (unpub-
lished data). Considering the increased number of CD11c 
DCs, these data suggest a dramatic increase in antigen pre-
sentation and/or costimulatory capacity accompanies the
development of gastritis in these mice. In line with this no-
tion, preliminary experiments indicate that MHC class II
molecule and costimulatory molecule B7.1 expression are
increased on gastric DCs from animals with AIG compared
with healthy animals (unpublished data).
Discussion
Here, we show that DCs of the gastric LN, but not of
peripheral or mesenteric LN, constitutively acquire, pro-
cess, and present PC-restricted H /K -ATPase in healthy,
untreated BALB/c mice. DCs are the only APC type in the
gastric LN that show detectable levels of such constitutive
antigen acquisition and presentation, with both CD8 hi
and CD8 lo gastric DC subsets able to activate H /K -
ATPase–specific T cells.
Results using both normal animals and transgenic models
with artificial “self-antigens” controlled by tissue-specific
promoters have suggested that DCs acquire antigen in tis-
sue sites and migrate to draining LN where processed forms
of these antigens are presented to T cells (for review see
reference 7). In accordance with these prior results, we
found MHC class II  CD11b  CD8   CD11c  DCs resid-
ing in stomach tissue in close association with PCs contain-
ing H /K -ATPase. In rare DCs in the stomach, H /K -
ATPase or H /K -ATPase fragments were present within
intracellular vesicles. The number of such antigen-contain-
ing DCs visualized by immunofluorescence is likely to be a
substantial underestimate of that involved in antigen uptake
and transport, given the probability of degradation of the
ATPase sufficient to render it undetectable in many
cells. H /K -ATPase–containing CD8   or CD8   and
CD11b  or CD11b  CD11c  DEC-205  DCs were also
observed in lymphoid tissue, but only in the gastric LN
draining the tissue source of the antigen. Taken together,
these data strongly suggest that DCs take up H /K -ATP-
ase self-antigen in normal stomach tissues and transport it
to the draining gastric LN.
Our ability to detect intracellular H /K -ATPase with
an Ab suggests that DCs might acquire this antigen in the
stomach mucosa by phagocytosis of fragments of PCs or of
entire apoptotic bodies. Immature DCs efficiently phago-
cytose apoptotic cells (31) and the high steady-state turn-
over rate of gastric PCs (23 d half-life; reference 12) should
favor a constant supply of H /K -ATPase antigen from
dying cells. The number of gastric LN-localized antigen-
containing DCs was markedly increased in animals with
AIG in concert with an increase in the number of DCs in-
filtrating the stomach mucosa and with a progressive loss of
H /K -ATPase–containing PCs. These data in diseased
animals are fully consistent with the idea that antigen ac-
quisition involves dead or dying PCs and may also help ex-
plain the progressive nature of autoimmune disease as well
as the accompanying epitope spreading, which presumably
requires increased presentation of what is normally a limit-
ing amount of tissue-specific antigen (13).
DCs in the gastric LN under steady-state conditions not
only acquired H /K -ATPase self-antigen, but also pre-
sented a processed form of this protein in association with
MHC class II molecules. Such presentation was not a post-
isolation artifact but was shown to represent the display of
antigen processed in situ. This is of some importance, as
several studies have shown that immature DCs take up an-
tigen efficiently (33–35) but typically do not form substan-
tial numbers of MHC class II–peptide complexes unless ex-
posed to inflammatory mediators (8–10, 36).
Numerous DC subsets have been described based on the
expression of various surface proteins such as DEC-205,
CD4, and CD8  (for review see reference 54). The role of
specific DC subsets in T cell tolerance remains contro-
versial (5, 55–60). The capacity of both CD8 high and
CD8 low DCs to present H /K -ATPase antigen in our
study may reflect the detection of both resident and migra-
tory DCs, respectively, which, due to activating signals, are
both able to process some of the acquired antigen. Alterna-
tively, CD8   DCs have recently been reported to derive
from CD8   DCs by a maturation process (61–63). Both
the maturing CD8 low and more mature CD8 high DCs
might be capable of H /K -ATPase antigen presentation
in the present model.
Constitutive presentation of H /K -ATPase in normal
mice does not result in the induction of AIG nor, it seems,
in the total inactivation and/or deletion of H /K -ATP-
ase–specific T cells, as documented by the numerous exam-
ples of AIG induction after the transfer of CD4  CD25  T
cells from normal donors into T cell–deficient hosts (19,
64) including those reported here. The presence of func-
tional autoreactive cells in animals in which self-antigen
presentation by DCs is apparent stands in contrast to a variety
of reports in transgenic systems (for review see references 7
and 65) and with the clear evidence for antigen-specific T
cell deletion mediated by DCs under “steady-state” non-
inflammatory conditions (5). Many of these deletion mod-
els involve just one TCR borne on transgenic T cells and it
Figure 7. Increase of TXA-23
stimulatory capacity of gastric
DCs during AIG. The capacity
of gastric DCs to induce IFN- 
production of TXA-23 T cells in
the absence of added antigen was
analyzed in untreated BALB/cnu/nu
mice and in BALB/cnu/nu mice 4
wk after the adoptive transfer of
CD4  CD25  T cells to induce
AIG. The dot plots show intracellular IFN-  production by TXA-23 cells
upon coculture for 12–16 h with gastric DCs from untreated BALB/cnu/nu
mice (week 0) and BALB/cnu/nu with AIG (week 4) in the absence of
added antigen. One representative experiment out of three is shown.1088 Constitutive Tissue Antigen Presentation by Dendritic Cells
is possible that only those T cells with TCR that are of the
highest affinity for the presented self-antigen undergo dele-
tion by DC-borne determinants. In addition, the deletion
of low affinity T cells by a transgenic self-antigen can take
several weeks (66). Because normal animals maintain a sub-
stantial thymic output, it is possible that steady-state anti-
gen presentation by DCs continually removes mature anti-
gen-specific cells from the repertoire, but that at any given
moment the recently exported cells not yet eliminated ac-
count for the capacity of transferred CD4  CD25  T cells
to induce disease. Finally, the high level of H /K -ATPase
acquired by DCs might result in the presentation of this an-
tigen by both tolerogenic and stimulatory subsets. Interac-
tion of the latter with T cells may impose a need for con-
trol of the activation by CD25  regulatory T cells (12).
Thus, these findings support the emerging view that both
DC-mediated deletion and immunoregulatory processes
contribute to the maintenance of an effective state of pe-
ripheral tolerance in the normal individual.
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